1. Home
  2. EVO vs ALIT Comparison

EVO vs ALIT Comparison

Compare EVO & ALIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • ALIT
  • Stock Information
  • Founded
  • EVO 1993
  • ALIT 2017
  • Country
  • EVO Germany
  • ALIT United States
  • Employees
  • EVO N/A
  • ALIT N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • ALIT Business Services
  • Sector
  • EVO Health Care
  • ALIT Consumer Discretionary
  • Exchange
  • EVO Nasdaq
  • ALIT Nasdaq
  • Market Cap
  • EVO 1.4B
  • ALIT 1.7B
  • IPO Year
  • EVO 2021
  • ALIT N/A
  • Fundamental
  • Price
  • EVO $4.15
  • ALIT $2.83
  • Analyst Decision
  • EVO Strong Buy
  • ALIT Strong Buy
  • Analyst Count
  • EVO 1
  • ALIT 6
  • Target Price
  • EVO $7.00
  • ALIT $8.75
  • AVG Volume (30 Days)
  • EVO 42.9K
  • ALIT 6.9M
  • Earning Date
  • EVO 11-05-2025
  • ALIT 11-05-2025
  • Dividend Yield
  • EVO N/A
  • ALIT 5.19%
  • EPS Growth
  • EVO N/A
  • ALIT N/A
  • EPS
  • EVO N/A
  • ALIT N/A
  • Revenue
  • EVO $912,894,891.00
  • ALIT $2,311,000,000.00
  • Revenue This Year
  • EVO N/A
  • ALIT $0.51
  • Revenue Next Year
  • EVO $10.78
  • ALIT $2.39
  • P/E Ratio
  • EVO N/A
  • ALIT N/A
  • Revenue Growth
  • EVO N/A
  • ALIT N/A
  • 52 Week Low
  • EVO $2.84
  • ALIT $2.86
  • 52 Week High
  • EVO $5.64
  • ALIT $8.93
  • Technical
  • Relative Strength Index (RSI)
  • EVO 63.61
  • ALIT 29.35
  • Support Level
  • EVO $4.05
  • ALIT $2.91
  • Resistance Level
  • EVO $4.27
  • ALIT $3.20
  • Average True Range (ATR)
  • EVO 0.09
  • ALIT 0.10
  • MACD
  • EVO 0.01
  • ALIT 0.01
  • Stochastic Oscillator
  • EVO 73.91
  • ALIT 3.87

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About ALIT Alight Inc.

Alight Inc is a technology-enabled services company delivering human capital management solutions to many of complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth and leaves benefits) solutions, currently operates under one reportable segment, Employer Solutions. The Company completed the Divestiture of Alight's Professional Services segment and Alight's Payroll & HCM Outsourcing business within the Employer Solutions segment. The company operates in USA states and International market too.

Share on Social Networks: